Merck KGaA, Darmstadt, Germany, Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology

Darmstadt, Germany, March 14, 2019 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of... Read more

Zhejiang University Joins MilliporeSigma’s CRISPR Core Partnership Program

March 14, 2019 MilliporeSigma’s global network of more than 80 CRISPR core partners promote ethical scientific exploration with genome editing via access to company’s network of experts Zhejiang University is first in China to use MilliporeSigma’s Arrayed CRISPR Library MilliporeSigma, a leading science and technology company, today announced a CRISPR core partnership with Zhejiang University... Read more

Merck KGaA, Darmstadt, Germany, Files Preliminary Proxy Statement Urging Versum Shareholders to Vote Against Entegris Acquisition.

12 MAR 2019 | DARMSTADT, GERMANY Merck KGaA, Darmstadt, Germany, is convinced that the proposed Entegris acquisition is not the best option available for Versum shareholders Merck KGaA, Darmstadt, Germany’s all-cash $48 per share proposal clearly superior to Entegris acquisition Merck KGaA, Darmstadt, Germany, a leading science and technology company, today filed a preliminary proxy statement with the U.S.... Read more

The Netherlands Cancer Institute (NKI) selects Labguru to further pioneering cancer research and treatment

NKI completes institute wide adoption of Labguru to increase efficiency and maximize productivity in the laboratory 12 March 2019, Cambridge, MA: BioData has announced The Netherlands Cancer Institute (NKI) has started an institute wide deployment of its flagship product Labguru. NKI has secured an institutional licence of Labguru’s Electronic Lab Notebook (ELN) for further collaboration across... Read more

Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model

San Diego, Calif. and Wilmington, Mass. – March 12, 2019 – Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced a licensing agreement with Charles River Laboratories International, Inc.’s Research Models and Services business. The agreement, designed to expand access to... Read more

GE Healthcare announces digital collaboration with Amgen to improve biomanufacturing performance reliability

Chicago, IL and Logan, Utah, USA – 11 March 2019 — GE Healthcare announces a digital data exchange collaboration program with Amgen, which will include advanced data analytics to increase the understanding of the relationship between raw material variability and process performance during the manufacture of biologic medicines. As a part of this initiative, GE... Read more

QIAGEN and Tecan announce collaboration to streamline preanalytical processing of QuantiFERON-TB Gold Plus

Germantown, Maryland, Hilden, Germany, and Männedorf, Switzerland, March 08, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Tecan Group AG (SIX Swiss Exchange: TECN), a global leader in laboratory automation and liquid handling technology, announced today a collaboration to improve the processing of QIAGEN’s QuantiFERON-TB Gold Plus (QFT-Plus) diagnostic test through the... Read more

Oxford Instruments and partners launch EU Horizon 2020 project ULISSES: Air sensors for everyone, everywhere

7 Mar Oxford Instruments Plasma Technology collaborate with EU partners to develop a new class of on-chip gas sensing technology within project ULISSES. The collaboration aims to develop a new class of miniaturized optical gas sensors on a chip, enabling low-cost distributed sensing nodes for the Internet of Things  (IoT). Stockholm, Sweden – Feb. 20,... Read more

Agilent and Imperial College London Strengthen Partnership

Agilent and Imperial College London Strengthen Partnership Agilent Measurement Suite at Imperial to boost research in molecular sciences SANTA CLARA, Calif., March 6, 2019 Agilent Technologies Inc. (NYSE: A) and Imperial College London have announced that, as part of its ongoing collaboration, several state-of-the-art analytical instruments have been installed into the college’s Molecular Sciences Research... Read more